Angiotensin converting enzyme (ACE) and ACE2 bind integrins and ACE2 regulates integrin signalling

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Clarke, Nicola E ^a   Fisher, Martin J ^a   Porter, Karen E ^a   Lambert, Daniel W ^b   Turner, Anthony J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA5 INTEGRIN; ANGIOTENSIN CONVERTING ENZYME 2; DIPEPTIDYL CARBOXYPEPTIDASE; INTEGRIN; ANGIOTENSIN II; ARGINYL-GLYCYL-ASPARTIC ACID; ARGINYLGLYCYLASPARTIC ACID; BETA1 INTEGRIN; OLIGOPEPTIDE;

ARTICLE; CELL ADHESION; CELL INTERACTION; CELL MEMBRANE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME REGULATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; AMINO ACID SEQUENCE; CELL LINE; CHEMICAL STRUCTURE; DRUG EFFECT; METABOLISM; PHYSIOLOGY;

AMINO ACID SEQUENCE; ANGIOTENSIN II; ANTIGENS, CD29; CELL ADHESION; CELL LINE; HUMANS; MODELS, MOLECULAR; OLIGOPEPTIDES; PEPTIDYL-DIPEPTIDASE A; SIGNAL TRANSDUCTION;

EID: 84859833392     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0034747     Document Type: Article

References (60)

1. Zhang F, Hu Y, Xu Q, Ye S, (2010) Different effects of angiotensin II and angiotensin-(1-7) on vascular smooth muscle cell proliferation and migration. PLoS One 5: e12323.
2. Garrido AM, Griendling KK, (2009) NADPH oxidases and angiotensin II receptor signaling. Mol Cell Endocrinol 302: 148-158.
3. Ji Y, Liu J, Wang Z, Liu N, (2009) Angiotensin II induces inflammatory response partly via toll-like receptor 4-dependent signaling pathway in vascular smooth muscle cells. Cell Physiol Biochem 23: 265-276.
4. Jimenez E, Perez de la Blanca E, Urso L, Gonzalez I, Salas J, et al. (2009) Angiotensin II induces MMP 2 activity via FAK/JNK pathway in human endothelial cells. Biochem Biophys Res Commun 380: 769-774.
5. Yoshiyama M, Nakamura Y, Omura T, Izumi Y, Matsumoto R, et al. (2005) Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice. Heart 91: 1080-1085.
6. Jin H, Yang R, Awad TA, Wang F, Li W, et al. (2001) Effects of early angiotensin-converting enzyme inhibition on cardiac gene expression after acute myocardial infarction. Circulation 103: 736-742.
7. Nakamura Y, Yoshiyama M, Omura T, Yoshida K, Izumi Y, et al. (2003) Beneficial effects of combination of ACE inhibitor and angiotensin II type 1 receptor blocker on cardiac remodeling in rat myocardial infarction. Cardiovasc Res 57: 48-54.
8. Clarke NE, Turner AJ, (2012) Angiotensin-converting enzyme 2: the first decade. Int J Hypertens 2012 307315.
9. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, et al. (2000) A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem. 275: 33238-33243.
10. Kassiri Z, Zhong J, Guo D, Basu R, Wang X, et al. (2009) Loss of Angiotensin-Converting Enzyme 2 Accelerates Maladaptive Left Ventricular Remodeling in Response to Myocardial Infarction. Circ. Heart Fail. 2: 446-455.
11. Yamamoto K, Ohishi M, Katsuya T, Ito N, Ikushima M, et al. (2006) Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II. Hypertension 47: 718-726.
12. Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, et al. (2003) Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A 100: 8258-8263.
13. Iwata M, Cowling RT, Gurantz D, Moore C, Zhang S, et al. (2005) Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects. American Journal of Physiology- Heart and Circulatory Physiology 289: H2356-2363.
14. Grobe JL, Mecca AP, Mao, H, Katovich MJ, (2006) Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension. Am J Physiol Heart Circ Physiol 290: H2417-2423.
15. Mercure C, Yogi A, Callera GE, Aranha AB, Bader M, et al. (2008) Angiotensin(1-7) Blunts Hypertensive Cardiac Remodeling by a Direct Effect on the Heart. Circ Res pp. 1319-1326.
16. Tallant EA, Ferrario CM, Gallagher PE, (2005) Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor. Am J Physiol. Heart and Circ Physiol 289: H1560-1566.
17. Qi Y, Shenoy V, Wong F, Li H, Afzal A, et al. (2011) Lentiviral mediated overexpression of Angiotensin-(1-7) attenuated ischemia-induced cardiac pathophysiology. Exp Physiol Epub.
18. Passier RC, Smits JF, Verluyten MJ, Daemen MJ, (1996) Expression and localization of renin and angiotensinogen in rat heart after myocardial infarction. Am J Physiol 271: H1040-1048.
19. Zisman LS, Meixell GE, Bristow MR, Canver CC, (2003) Angiotensin-(1-7) formation in the intact human heart: in vivo dependence on angiotensin II as substrate. Circulation 108: 1679-1681.
20. Burrell L, Risvanis J, Kubota E, Dean, R, MacDonald P, et al. (2005) Myocardial infarction increases ACE2 expression in rat and humans. European Heart Journal 26: 369-375.
21. Der Sarkissian S, Grobe JL, Yuan L, Narielwala DR, Walter GA, et al. (2008) Cardiac Overexpression of Angiotensin Converting Enzyme 2 Protects the Heart From Ischemia-Induced Pathophysiology. Hypertension 51: 712-718.
22. Lambert DW, Clarke NE, Turner AJ, (2009) Not just angiotensinases: new roles for the angiotensin-converting enzymes. Cell Mol Life Sci.
23. Camargo SM, Singer D, Makrides V, Huggel K, Pos KM, et al. (2009) Tissue-specific amino acid transporter partners ACE2 and collectrin differentially interact with hartnup mutations. Gastroenterology 136: 872-882.
24. Lambert DW, Clarke NE, Hooper NM, Turner AJ, (2008) Calmodulin interacts with angiotensin-converting enzyme-2 (ACE2) and inhibits shedding of its ectodomain. FEBS Letters 582: 385-390.
25. Lin Q, Keller RS, Weaver B, Zisman LS, (2004) Interaction of ACE2 and integrin beta1 in failing human heart. Biochimica et Biophysica acta 1689: 175-178.
26. van den Borne SW, Diez J, Blankesteijn WM, Verjans J, Hofstra L, et al. (2010) Myocardial remodeling after infarction: the role of myofibroblasts. Nat Rev Cardiol 7: 30-37.
27. Sun M, Opavsky MA, Stewart DJ, Rabinovitch M, Dawood F, et al. (2003) Temporal Response and Localization of Integrins {beta}1 and {beta}3 in the Heart After Myocardial Infarction: Regulation by Cytokines. Circulation 107: 1046-1052.
28. Krishnamurthy P, Subramanian V, Singh M, Singh K, (2006) Deficiency of 1 integrins results in increased myocardial dysfunction after myocardial infarction. Heart 92: 1309.
29. Epelman S, Shrestha K, Troughton RW, Francis GS, Sen S, et al. (2009) Soluble angiotensin-converting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomes. J Card Fail 15: 565-571.
30. Towler P, Staker B, Prasad SG, Menon S, Tang, J, et al. (2004) ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. J Biol Chem 279: 17996-18007.
31. Kerjaschki D, Ojha PP, Susani M, Horvat R, Binder S, et al. (1989) A beta 1-integrin receptor for fibronectin in human kidney glomeruli. Am J Pathol 134: 481-489.
32. Guy JL, Lambert DW, Turner AJ, Porter KE, (2008) Functional angiotensin-converting enzyme 2 is expressed in human cardiac myofibroblasts. Experimental Physiology 93: 579-588.
33. Ocaranza MP, Godoy I, Jalil JE, Varas M, Collantes P, et al. (2006) Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat. Hypertension 48: 572-578.
34. Goulter AB, Goddard MJ, Allen JC, Clark KL, (2004) ACE2 gene expression is up-regulated in the human failing heart. BMC Med 2: 19.
35. Grobe JL, Der Sarkissian S, Stewart JM, Meszaros JG, Raizada MK, et al. (2007) ACE2 overexpression inhibits hypoxia-induced collagen production by cardiac fibroblasts. Clin Sci (Lond) 113: 357-364.
36. Wong DW, Oudit GY, Reich H, Kassiri Z, Zhou J, et al. (2007) Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury. Am J Pathol 171: 438-451.
37. Roman J, McDonald JA, (1992) Expression of fibronectin, the integrin alpha 5, and alpha-smooth muscle actin in heart and lung development. Am J Respir Cell Mol Biol 6: 472-480.
38. Rosenow F, Ossig R, Thormeyer D, Gasmann P, Schluter K, et al. (2008) Integrins as antimetastatic targets of RGD-independent snake venom components in liver metastasis. Neoplasia. 10: 168-76.
39. Takagi J, (2007) Structural basis for ligand recognition by integrins. Curr Opin Cell Biol 19: 557-564.
40. Bar-Shavit R, Sabbah V, Lampugnani MG, Marchisio PC, Fenton JW II, et al. (1991) An Arg-Gly-Asp Sequence with thrombin promotes endothelial cell adhesio. J. Cell Biol. 112: 335-344.
41. Bode W, Turk D, Karshikov A, (1992) The refined 1.9A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structur, electrostatic properties, detailed active-site geometry, and structure-function relationships. Protein Sci. 1: 426-71.
42. Bar-Shavit R, Eskohjido Y, Fenton JW II, Esko JD, Vlodavsky I, (1993) Thrombin adhesive properties: induction by plasmin and heparin sulphate. J. Cell Biol. 123: 1279-87.
43. Takeda S, Igarashi T, Mori H, Araki S, (2006) Crystal structures of VAP1 reveal ADAMs' MDC domain architecture and its unique C-shaped scaffold. EMBO J 25: 2388-2396.
44. Zigrino P, Nischt R, Mauch C, (2011) The disintegrin-like and cysteine-rich domains of ADAM-9 mediate interactions between melanoma cells and fibroblasts. J Biol Chem 286: 6801-6807.
45. Long EO, (2011) ICAM-1: getting a grip on leukocyte adhesion. J Immunol 186: 5021-5023.
46. Chen H, Sampson NS, (1999) Mediation of sperm-egg fusion: evidence that mouse egg alpha6beta1 integrin is the receptor for sperm fertilinbeta. Chem Biol 6: 1-10.
47. Porter KE, Turner NA, (2009) Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol Ther 123: 255-278.
48. Soro-Paavonen A, Gordin D, Forblom C, Rosengard-Barlund M, Waden J, et al. (2012) Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications. J. Hypertens. 2: 375-83.
49. Lambert DW, Yarski M, Warner FJ, Thornhill P, Parkin ET, et al. (2005) Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). J. Biol. Chem. 280: 30113-30119.
50. Haga S, Yamamoto N, Nakai-Murakami C, Osawa Y, Tokunaga K, et al. (2008) Modulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entry. Proc Natl Acad Sci U S A 105: 7809-7814.
51. Hanks SK, Calalb MB, Harper MC, Patel SK, (1992) Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin. Proc Natl Acad Sci U S A 89: 8487-8491.
52. Young-Pearse TL, Chen AC, Chang R, Marquez C, SelkoeDJ, (2008) Secreted APP regulates the function of full-length APP in neurite outgrowth through interaction with integrin beta1. Neural Dev 3: 15.
53. Mores A, Matziari M, Beau F, Cuniasse P, Yiotakis A, et al. (2008) Development of potent and selective phosphinic peptide inhibitors of angiotensin-converting enzyme 2. J Med Chem 51: 2216-2226.
54. Balyasnikova IV, Metzger R, Franke FE, Conrad N, Towbin H, et al. (2008) Epitope mapping of mAbs to denatured human testicular ACE (CD143). Tissue Antigens 72: 354-368.
55. Balyasnikova IV, Metzger R, Franke FE, Danilov SM, (2003) Monoclonal antibodies to denatured human ACE (CD 143), broad species specificity, reactivity on paraffin sections, and detection of subtle conformational changes in the C-terminal domain of ACE. Tissue Antigens 61: 49-62.
56. Rushworth CA, Guy JL, Turner AJ, (2008) Residues affecting the chloride regulation and substrate selectivity of the angiotensin-converting enzymes (ACE and ACE2) identified by site-directed mutagenesis. FEBS J. 275: 6033-42.
57. Pola S, Cattaneo MG, Vicentini LM, (2003) Anti-migratory and anti-invasive effect of somatostatin in human neuroblastoma cells: involvement of Rac and MAP kinase activity. J Biol Chem. 278: 40601-6.
58. Turner NA, Porter KE, Smith WH, White HL, Ball SG, et al. (2003) Chronic beta2-adrenergic receptor stimulation increases proliferation of human cardiac fibroblasts via an autocrine mechanism. Cardiovasc Res 57: 784-792.
59. Porter KE, Turner NA, O'Regan DJ, Balmforth AJ, Ball SG, (2004) Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA. Cardiovasc Res 61: 745-755.
60. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, et al. (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76-85.